New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

Does GLP-1RA use impact the risk of thyroid cancer? GLP-1RAs are highly effective medications used to treat T2D and obesity while simultaneously conferring protection against cardiovascular ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

Over the past decade, there has been a substantial increase in GLP-1RA use, and some research has highlighted its gastrointestinal side effects. Considering the wide use of GLP-1RAs, it is ...

Glucagon-like peptide-1 receptor agonists (GLP-1RA) drugs like Ozempic and Wegovy are called “miracle drugs” by some pharmacists for their ability to help those with diabetes to lose weight. The drugs ...

Efruxifermin (EFX) with GLP-1RA significantly reduces hepatic fat fraction and improves fibrosis in MASH and T2D patients. The study involved 31 patients over 12 weeks, showing EFX enhances GLP ...

While GLP-1RA drugs display effectiveness against a wide array of health problems, the magnitude of associated benefits is modest—about a 10 percent to 20 percent reduction for most outcomes.